Results

Total Results: 6,952 records

Showing results for "weeks".

401. 151. Treatment Recommendations: Medications-Clonidine | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide151.html
     October 01, 2014 - The dose duration also varied across the clinical trials, ranging from 3-10 weeks.

402. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/72495/psn-pdf
     November 25, 2020 - homes in Italy found that one third of facilities reported at least one adverse event during the early weeks

403. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/72720/psn-pdf
     February 10, 2021 - February 10, 2021 Austin JM, Weeks K, Pronovost PJ.

404. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/73528/psn-pdf
     July 28, 2021 - safety-implications-different-forms-understaffing-among-nurses-during-covid- 19-pandemic During the first weeks

405. Section 8: The Care Management Evidence Base (continued) | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/medicaidmgmt/mm8a.html
     October 01, 2014 - with telephonic care management were significantly more likely to have asthma planning visits at 2 weeks … One study showed that the likelihood of having asthma planning visits at 2 weeks increased significantly … Similarly, the same study found that after 2 weeks, no differences occurred in asthma planning visits … Provider education interventions also found that the likelihood of having asthma planning visits at two weeks … Similarly, the same study found that after two weeks, no differences in asthma planning visits or acute

406. Final Evidence Summary: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-c-screening
     March 02, 2020 - after the completion of therapy in all studies except for 1, which measured SVR at 14 weeks. … Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection. … Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. … Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir ( … Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection.

407. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/846125/psn-pdf
     March 15, 2023 - Within two weeks from the time that pulmonary and critical care clinicians sounded an alarm about the … The team responded and addressed these problems within weeks and created the I-READI framework as a … During the earlier weeks of the COVID-19 pandemic, frontline workers in the University of Pennsylvania … mortality rates for patients requiring reintubation are high, at roughly 30% to 40%.7 Results In the two weeks

408. Final Research Plan: Anxiety Disorders in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/anxiety-adults-screening
     August 27, 2020 - interview or a nonbrief [>5 minutes] unstructured interview with mental health clinician) within 2 weeks … Outcome assessment timing KQs 1, 3–5: ≥6 weeks after baseline, except for suicide death or self-harm … KQ 2: Maximum of 2 weeks between screening and reference standard.   … interview or a nonbrief [>5 minutes] unstructured interview with mental health clinician) within 2 weeks

409. Final Research Plan: Depression and Suicide Risk in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-depression-suicide-risk-adults
     September 03, 2020 - interview or a nonbrief [>5 minutes] unstructured interview with mental health clinician) within 2 weeks … Outcome assessment timing KQs 1, 3–5: ≥6 weeks after baseline, except for suicide death or self-harm … KQ 2: Maximum of 2 weeks between screening and reference standard.   … interview or a nonbrief [>5 minutes] unstructured interview with mental health clinician) within 2 weeks

410. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/866901/psn-pdf
     October 09, 2024 - In this study, 758 mammograms were read by human radiologists with no AI support and read again 6 weeks

411. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/37872/psn-pdf
     January 11, 2017 - January 11, 2017 Percarpio KB, Watts V, Weeks WB.

412. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/34699/psn-pdf
     January 04, 2017 - January 4, 2017 Weeks WB, Waldron J, Foster T, et al.

413. ElderTree Baseline Survey (pdf file)
     digital.ahrq.gov/sites/default/files/docs/survey/eldertree-baseline-survey.pdf
     October 16, 2014 - How have they been going for you in the last few weeks? … Over the last 2 weeks, how often did you experience the following situations? … Over the last 2 weeks, how often did you experience the following situations? … EMOTIONAL STATUS 27.Over the last 2 weeks … How has it been going for you in the last few weeks helping this person… Don’t have to do it

414. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
     May 07, 2010 - versus a direct renin inhibitor For all included studies, please also indicate the longest length (weeks … or # months follow-up, or write “NS” if length of follow-up not specified) - IN AcVR (specify # weeks … or # months follow-up, or write “NS” if length of follow-up not specified) - IN ArVR (specify # weeks … non-RCTs, cohorts, etc.); cross-sectional studies acceptable if time on treatment reported and ≥ 12 weeks … Treatment duration/length of followup: - Exclude if treatment duration or longest followup < 12 weeks

415. App-D-Opioid-Chronic-Pain-Surveillance-Report-3 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
     September 30, 2015 - Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration: 6 weeks … , adjusted for race and depression) Pain severity (0 to 10): 7.15 (SD 2.38) vs. 7.36 (SD 1.55) at 9 weeks … , mean difference -9.20 (95% CI -20.25 to 1.85)* NR NR Fair Maheu, 2022 RCT Duration: 12 weeks; optional … B 8 weeks Pain intensity (NRS 0 to 10, LSM change at followup): -2.7 (SE 0.1) vs. -2.5 (SE 0.1) Pain … B, at 8 weeks Pain intensity (WOMAC 0 to 10 NRS, mean change from baseline): –2.17 (0.24) vs. –2.28 (

416. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/42867/psn-pdf
     February 13, 2014 - February 13, 2014 Willson MN, Greer CL, Weeks DL.

417. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/34931/psn-pdf
     April 06, 2011 - April 6, 2011 Schmidek JM, Weeks WB.

418. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/60224/psn-pdf
     April 15, 2020 - summaries was low, with 55% (median) transferred to PCPs within 48 hours and 85% (median) within 4-weeks

419. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/60839/psn-pdf
     August 26, 2020 - visits during a four-week period at the height of the pandemic was significantly less than in the four weeks

420. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/61043/psn-pdf
     October 21, 2020 - study, adult patients who were discharged directly home after an ICU admission were followed for 8 weeks